• / Free eNewsletters & Magazine
  • / My Account
Home>Insiders>Robert J. Smith

Robert J. Smith

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. FDA Panel Backs Cholesterol Drug, but Raises Concerns

    FDA Panel Backs Cholesterol Drug, but Raises Concerns

  2. One Year Is Not Enough

    These outperformers in 2014 warrant a wait-and-see attitude.

  3. One Year Is Not Enough

    These outperformers in 2014 warrant a wait-and-see attitude.

  4. 4 High-Profile Manager Changes

    What to make of recent changes at T. Rowe Price, Fidelity, Artisan, and First Eagle.

  5. T. Rowe Price Remains on Top

    Departures of investment staff are worth watching, though. 

  6. T. Rowe Price Remains on Top

    Departures of investment staff are worth watching, though.

  7. The 'Chicken' Approach to Emerging Markets Could Be Just the Ticket

    Diversified foreign-stock funds with ample emerging-markets exposure offer a great entry point into developing regions.

  8. Early Report Cards on Three International-Stock Managers

    The skippers at these prominent foreign funds get mixed grades so far.

  9. There's Less Than Meets the Eye for These Funds

    Four funds whose Morningstar Analyst Ratings are worse than their star ratings.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.